IPO Premiums
IPO calendar
WBListed

Windlas Biotech Limited

Bookbuilding IPO · NSE, BSE

Price band
₹448-₹460
Lot size
30 shares
Issue amount
₹402 cr
Total subscription
0×
Current price₹906.1
Listing price ₹437
Watch live price ↗
Opens
4 Aug 2021
Closes
6 Aug 2021
Allotment
11 Aug 2021
Listing
16 Aug 2021

Offer at a glance

Issue overview

Issue size
87,29,023 shares
Face value
₹5 per share
Minimum investment
₹13,440
Fresh issue
₹165 cr
Offer for sale
₹237 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹13,800
Issue type
Bookbuilding IPO
Shares before issue
1,82,07,419
Shares after issue
2,17,94,375

Lot sizes

CategoryLotsSharesAmount
RETAIL130₹13,800
sHNI15450₹2,07,000
bHNI732,190₹10,07,400

Share reservation

QIB50%
NII (HNI)15%
RETAIL35%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

0408020 May: ₹80
20 May₹8020 May

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
02,0004,0006,000Mar-19 · Revenue: 3,115.25Mar-19 · Profit after tax: 638.22Mar-19Mar-20 · Revenue: 3,313.39Mar-20 · Profit after tax: 162.13Mar-20Mar-21 · Revenue: 4,306.95Mar-21 · Profit after tax: 155.7Mar-21
RevenueProfit after tax

Company information

Company profile

Incorporated in 2001, Windlas Biotech Ltd is a prominent pharmaceutical company in India’s CDMO segment, offering end-to-end services from product discovery and development to licensing and commercial manufacturing of generic and complex generic products. The company also markets its own branded products in the trade generics and OTC segments, focusing on chronic therapeutic categories related to lifestyle disorders. Windlas Biotech operates across three verticals: CDMO services, domestic trade generics and nutraceuticals, and exports. Its marquee clients include Pfizer, Sanofi India, Cadila Healthcare, Emcure Pharmaceuticals, Eris Lifesciences, Intas Pharmaceuticals, and Systopic Laboratories. The company’s Dehradun-based manufacturing facilities have an installed capacity of 7,063.83 million tablets/capsules, 54.46 million pouches/sachets, and 61.08 million liquid bottles.

Strengths

  • Leading CDMO Player: Top company in India’s pharmaceutical formulation CDMO segment.
  • Therapeutic Focus: Strong emphasis on chronic therapy products.
  • Advanced Facilities: State-of-the-art manufacturing units in Dehradun, Uttarakhand.
  • Experienced Leadership: Professional promoters supported by a skilled senior management team.
  • Innovative Portfolio: Offers complex generic products.
  • Strong Financials: Demonstrates a robust track record of financial performance.

Promoters

Ashok Kumar Windlass

Hitesh Windlass

Manoj Kumar Windlass

AKW WBL Family Pvt Trust

Registrar & documents

Lead manager

Dam Capital Advisors Limited, IIFL Capital Services Limited, SBI Capital Markets Limited

Registered office

40/1, Mohabewala Industrial Area, Dehradun, 248110

+91 135 6608000

[email protected]Company website ↗

Frequently Asked Questions

What is Windlas Biotech IPO GMP today?

As of today, Windlas Biotech IPO Grey Market Premium (GMP) is reported at +₹80 per share. Based on the upper price band of ₹460, the estimated listing price is ₹540 (+17.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Windlas Biotech IPO?

The minimum bid lot size for Windlas Biotech IPO is 30 shares. At the cut-off price of ₹460 per share, retail investors need a minimum application amount of ₹13,800 per lot. Retail applicants can apply for a maximum of 14 lots (up to ₹2,00,000).

When will Windlas Biotech IPO allotment status be announced?

The allotment status for Windlas Biotech IPO is scheduled to be finalized on 11 Aug 2021. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Windlas Biotech IPO allotment status online by PAN?

To check Windlas Biotech IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Windlas Biotech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Windlas Biotech IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums